Lv22
130 积分 2024-05-27 加入
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
3小时前
已完结
The dynamic spectrum of steatotic liver disease: the global perspective
5天前
已完结
Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset
18天前
已完结
Single cell-resolved transcriptional dynamics of human subcutaneous adipose tissue during lifestyle- and bariatric surgery-induced weight loss
6个月前
已完结
The role of interferon-γ in cardiovascular disease: an update
11个月前
已完结
Cytokeratin 18 in nonalcoholic fatty liver disease: value and application
1年前
已完结
Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis
1年前
已完结
皖公网安备34019202002308
